期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

骨质疏松药物研究进展 被引量：5

暂未订购
导出
摘要 骨质疏松症（osteoporosis,OP）是老年人常见病和多发病之一,分为原发性、继发性和特发性三大类,以原发性骨质疏松最为多见,其主要临床表现为骨痛和骨折。目前治疗原发性骨质疏松的药物主要有：①抑制骨吸收的药物,包括雌激素、降钙素、双膦酸盐等;②增加骨形成的药物包括甲状旁腺激素、氟化物、硼剂。其他辅助药物包括钙剂、活性维生素D3等。现就骨质疏松症治疗药物研究进展作一综述。
作者 张林基 张元平
机构地区 解放军 兰州军区临潼疗养院
出处 《西北国防医学杂志》 CAS 2011年第3期202-203,共2页 Medical Journal of National Defending Forces in Northwest China
关键词 骨质疏松 药物 治疗 骨吸收抑制剂
分类号 R580 [医药卫生—内分泌]
  • 相关文献

参考文献19

  • 1吕靖,马彩玲.绝经后骨质疏松症的治疗新进展[J].医学综述,2007,13(1):62-63. 被引量：38
  • 2Davies GC, Huster WJ, Plouffe L,et al. Adverse e - vents reported by postmenopausal women in controlledtrials with raloxifene[ J]. J Obstet Gynecol, 1999,93:558.
  • 3Barrett - Connor E, Grady D. Raloxifene and cardiovascular events in osteoporotic postmenopausal women : four - year resuits from the MORE( Multiple Outcomesof Raloxifene Eval- uation) randomized trial [ J ]. JAMA, 2002,287 : 847.
  • 4Muller K, Wiesenberg I, Jaeggi K, et al. Effects of thebi- sphosphonate zoledronate on bone loss in the ovariec - tomized and in the adjuvant arthritic rat[ J]. Arzneimittelforschung, 1998, (48) :81 - 86.
  • 5张亚,公瑞煜,石朝周.抑制骨吸收药物的现状及进展[J].国外医学（老年医学分册）,2003,24(2):91-94. 被引量：15
  • 6张绪金,唐英华,刘忠厚.降钙素进展[J].中国骨质疏松杂志,2004,10(1):96-97. 被引量：22
  • 7Gennari C. Analgesic effect of calcitonin in osteoporosis [ J ]. Bone, 2002,305 : 67.
  • 8Raginster JY, Felsenberg D, Pavo I,et al. Effect ofraloxifene combined with monofluorophosphate as compared with monofluorophosphate alone in postmenopausal women with low bone mass : arandomized , controlled trial [ J ]. Osteoporos Int,2003,14:741 - 749.
  • 9聂晶,卢良华,孙军.预防和治疗骨质疏松症的有效药物依普黄酮[J].中国现代应用药学,2002,19(1):7-9. 被引量：22
  • 10Elaena Q, Helen K. Teriparatide: A Review [ J ]. clinical thearpeutics ,2004,26 (6) : 841 - 854.

二级参考文献135

  • 1王维敏,马向华.代谢综合征患者瘦素抵抗的研究[J].医学研究生学报,2004,17(7):610-612. 被引量：9
  • 2杨玲,殷晓进.锶与骨矿代谢[J].中国骨质疏松杂志,2004,10(3):384-387. 被引量：17
  • 3Chesnut CH, Silverman S, Andriano K, et al. A randomized trial of nasal spray salmon calcitonin in postmcnopausal women with established osteoporosis:the prevent recurrence of osteoporotic fractures study [In Process Citation]. Am J Med, 2000,109:206-276.
  • 4Wimalawansa SJ. Prevention and treatment of osteoponmis: efficacy of combination of hormone replacement therapy with other antiresotptive agetns. J Clin Densitiom,2000,3 : 187-190.
  • 5Fujita T, Fujii Y, Miyauchi A, et al. Comparision of antiresorptive activivities of ipriflavone, an isoflavone derivative and eclatonin, an evolve using novel CT-like molecules. J Bone Miner Metab, 1999,17:289-295.
  • 6Petersen MM. Effect of nasal salmon calcitonin on post-traumatic osteropenia following ankle fracture. Acta Orthop Stand, 1998,19:347-350.
  • 7Grigoriou O. Effect of nasal administration of Calcitonin in oophorectomized Women : 2-year controlled double-blind study. Maturitas, 1997,28:147-151.
  • 8Montemurro L, Schiraldi G, Fraioli P, et al. Prevention of corticosteroidinduced ostcoporosis with salmon calcitonin in sarcoid patients. Calcif Tissue Int, 1991,49:71.
  • 9Moe SM. The treatment of steroid-induced bone loss in transplantation .Curr Opin Nephrol Hypertens, 1997,6(6) :544-549.
  • 10Wallach S, Rousseau G,Martin L. Effects d calcitonin on animal and in vitro models of skeletal metabolism. Bone, 1999,25 : 509-516.

共引文献100

同被引文献89

引证文献5

二级引证文献8

西北国防医学杂志
2011年 第3期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部